Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China

Molecular Human Reproduction

Volumn 12, Issue 1, 2006, Pages 35-39

  Shan, Kang ^a   Lian Fu, Zuo ^b   Hui, Du ^a   Wei, Guo ^b   Na, Wang ^b   Xia, Jin ^a   Yan, Li ^a,b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Hebei Cancer Institute   (China)

Author keywords

Adenomyosis; Endometriosis; Matrix metalloproteinase 7; Matrix metalloproteinase 9; Single nucleotide polymorphism

Indexed keywords

GELATINASE B; MATRILYSIN;

ADENOMYOSIS; ADULT; ARTICLE; CHINA; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN POLYMORPHISM; RISK ASSESSMENT;

ADULT; CHINA; ENDOMETRIOSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 33645107485     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gal002     Document Type: Article

References (45)

1. Adachi Y, Yamamoto H, Itoh F, Hinoda Y, Okada Y and Imai K (1999) Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancer. Gut 45,252-258.
2. AFS (1985) Revised American Fertility Society classification of endometriosis. Fertil Steril 43,351-352.
3. Aglund K, Rauvala M, Puistola U, Angstrom T, Turpeenniemi-Hujanen T, Zackrisson B and Stendahl U (2004) Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage. Gynecol Oncol 94,699-704.
4. Ajisaka H, Yonemura Y and Miwa K (2004) Correlation of lymph node metastases and expression of matrix metalloproteinase-7 in patients with gastric cancer. Hepatogastroenterology 51,900-905.
5. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A and Engler JA (1993) Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 4,197-250.
6. Bruner-Trap KL, Eisenberg E, Yeaman GR, Anderson TA, McBean J and Osteen KG (2002) Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice. J Clin Endocrinol Metab 87,4782-4791.
7. Chung HW, Wen Y, Chun SH, Nezhat C, Woo BH and Polan ML (2001) Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: A rationale for endometriotic invasiveness. Fertil Steril 75,152-159.
8. Cox KE, Piva M and Sharpe-Timms KL (2001) Differential regulation of matrix metalloproteinase-3 gene expression in endometriotic lesions compared with endometrium. Biol Reprod 65,1297-1303.
9. Fang S, Jin X, Wang R, Li Y, Guo W, Wang N, Wang Y, Wen D, Wei L and Zhang J (2005) Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Carcinogenesis 26,481-486.
10. Ferrand PE, Parry S, Sammel M, Macones GA, Kuivaniemi H, Romero R and Strauss JF 3rd (2002) A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod 8,494-501.
11. Fiotti N, Zivadinov R, Altamura N, Nasuelli D, Bratina A, Tommasi MA, Bosco A, Locatelli L, Grop A, Cazzato G et al. (2004) MMP-9 microsatellite polymorphism and multiple sclerosis. J Neuroimmunol 152,147-153.
12. Ghilardi G, Biondi ML, Erario M, Guagnellini E and Scorza R (2003) Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms. Clin Chem 49,1940-1942.
13. Gilabert-Estelles J, Estelles A, Gilabert J, Castello R, Espana F, Falco C, Romeu A, Chirivella M, Zorio E and Aznar J (2003) Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis. Hum Reprod 18,1516-1622.
14. Grieu F, Li WQ and Iacopetta B (2004) Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype. Breast Cancer Res Treat 88,197-204.
15. Gumbiner BM (1996) Cell adhesion: The molecular basis of tissue architecture and morphogenesis. Cell 84,345-357.
16. Haro H, Crawford HC, Fingleton B, Shinomiya K, Spengler DM and Matrisian LM (2000) Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. J Clin Invest 105,143-150.
17. Igney FH and Krammer PH (2002) Death and anti-death: Tumour resistance to apoptosis. Nat Rev Cancer 2,277-288.
18. Jordan RC, Macabeo-Ong M, Shiboski CH, Dekker N, Ginzinger DG, Wong DT and Schmidt BL (2004) Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer. Clin Cancer Res 10,6460-6465.
19. Jormsjo S, Whatling C, Walter DH, Zeiher AM, Hamsten A and Eriksson P (2001) Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 21,1834-1839.
20. Kang S, Wang Y, Zhang JH, Guo W and Na W and Li Y (2005) The function of SNP in the MMP1 and MMP3 promoter is associated with susceptibility to endometriosis in china. Mol Hum Reprod 11,423-427.
21. Kioi M, Yamamoto K, Higashi S, Koshikawa N, Fujita K and Miyazaki K (2003) Matrilysin (MMP-7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model. Oncogene 22,8662-8670.
22. Kokorine I, Nisolle M, Donnez J, Eeckhout Y, Courtoy PJ and Marbaix E (1997) Expression of interstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesions. Fertil Steril 68,246-251.
23. Leeman MF, Curran S and Murray GI (2003) New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J Pathol 201,528-534.
24. Matsumura S, Oue N, Nakayama H, Kitadai Y, Yoshida K, Yamaguchi Y, Imai K, Nakachi K, Matsusaki K, Chayama K et al. (2005) A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer. J Cancer Res Clin Oncol 131,19-25.
25. Mattey DL, Nixon NB, Dawes PT, Ollier WE and Hajeer AH (2004) Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis. Genes Immun 5,147-149.
26. Miller SA, Dybes DD and Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16,1215.
27. Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM and Mareel M (2001) Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 114,111-118.
28. Nojiri T, Morita H, Imai Y, Maemura K, Ohno M, Ogasawara K, Aizawa T, Saito A, Hayashi D, Hirata Y et al. (2003) Genetic variations of matrix metalloproteinase-1 and -3 promoter regions and their associations with susceptibility to myocardial infarction in Japanese. Int J Cardiol 92,181-186.
29. Ohashi K, Nemoto T, Nakamura K and Nemori R (2000) Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas. Cancer 88,2201-2209.
30. Pollanen PJ, Karhunen PJ, Mikkelsson J, Laippala P, Perola M, Penttila A, Mattila KM, Koivula T and Lehtimaki T (2001) Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene: An autopsy study. Arterioscler Thromb Vasc Biol 21,1446-1450.
31. Poncelet C, Leblanc M, Walker-Combrouze F, Soriano D, Feldmann G, Madelenat P, Scoazec JY and Darai E (2002) Expression of cadherins and CD44 isoforms in human endometrium and peritoneal endometriosis. Acta Obstet Gynecol Scand 81,195-203.
32. Poulaki V, Mitsiades CS and Mitsiades N (2001) The role of Fas and FasL as mediators of anticancer chemotherapy. Drug Resist Updat 4,233-242.
33. Powell WC, Fingleton B, Wilson CL, Boothby M and Matrisian LM (1999) The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr Biol 9,1441-1447.
34. Quantin B, Murphy G and Breathnach R (1989) Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members. Biochemistry 28,5327-5334.
35. Schneider P, Holler N, Bodmer JL, Hahne M, Frei K, Fontana A and Tschopp J (1998) Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with down-regulation of its proapoptotic activity and loss of liver toxicity. J Exp Med 187, 1205-1213.
36. Scotti S, Regidor PA, Schindler AE and Winterhager E (2000) Reduced proliferation and cell adhesion in endometriosis. Mol Hum Reprod 6,610-617.
37. Szamatowicz J, Laudaski P and Tomaszewska I (2002) Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1: a possible role in the pathogenesis of endometriosis. Hum Reprod 17,284-288.
38. Wang Y, Fang SM, Wei LH, Wang R, Jin X, Wen DG, Li Y, Guo W, Wang N and Zhang JH (2005) Association of the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene with non-small cell lung carcinoma. Lung Cancer 49,155-161.
39. Wilson CL and Matrisian LM (1996) Matrilysin: An epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 28,123-136.
40. Ye S (2000) Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol 19,623-629.
41. Yu C, Pan K, Xing D, Liang G, Tan W, Zhang L and Lin D (2002) Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res 62,6430-6433.
42. Yu YY, Guo XH, Qian JH, Du Zhang JH and XJ (2003) The expression of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 3 in endometriosis. Prog Obstet Gynecol 12,25-27.
43. Zhang B, Ye S, Herrmann SM, Eriksson P, de Maat M, Evans A, Arveiler D, Luc G, Cambien F, Hamsten A et al. (1999) Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99,1788-1794.
44. Zhang JH, Jin X, Fang S, Li Y, Wang R, Guo W, Wang N, Wang Y, Wen D, Wei L et al. (2004) The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastases in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma. Carcinogenesis 25,2519-2524.
45. Zhang J, Jin X, Fang S, Wang R, Li Y, Wang N, Guo W, Wang Y, Wen D, Wei L et al. (2005) The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Carcinogenesis 26,1748-1753.